Drugs / Restylane Silk
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03324997 | Jan 2018 | — | Heidi Waldorf | Withdrawn | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03460158 | Aug 2020 → Feb 2024 | — | University of Pennsylvania | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Restylane Silk | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03460158 ↗ |
| Modality | Other / unclassified | “Restylane Silk is a temporary hyaluronic acid filler currently approved for the lips and fine lines around the mouth.” NCT03324997 ↗ |
| Route | Other | “submucosal implantation” NCT03460158 ↗ |